 | • レポートコード：D005-00140 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、脳腫瘍治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。脳腫瘍治療の種類別市場規模（外科、放射線療法、標的療法、化学療法、免疫療法）、用途別市場規模（病院、腫瘍治療センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Philips Healthcare、Merck、Novartis、Hitachi Medical、Roche、DelMar Pharmaceuticals、GE Healthcare、AstraZeneca、Novocure ・地域別グローバル市場分析 2015年-2020年 ・脳腫瘍治療の北米市場（アメリカ、カナダ、メキシコ） ・脳腫瘍治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・脳腫瘍治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・脳腫瘍治療の南米市場（ブラジル、アルゼンチン） ・脳腫瘍治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：外科、放射線療法、標的療法、化学療法、免疫療法 ・用途別分析：病院、腫瘍治療センター、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Brain Tumor Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1552.3 million by 2025, from USD 1060.2 million in 2019.
The Brain Tumor Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Brain Tumor Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Brain Tumor Therapeutics market has been segmented into:
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Immunotherapy
By Application, Brain Tumor Therapeutics has been segmented into:
Hospitals
Oncology Treatment Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Brain Tumor Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Brain Tumor Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Brain Tumor Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Brain Tumor Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Brain Tumor Therapeutics Market Share Analysis
Brain Tumor Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Brain Tumor Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Brain Tumor Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Brain Tumor Therapeutics are:
Pfizer
Philips Healthcare
Merck
Novartis
Hitachi Medical
Roche
DelMar Pharmaceuticals
GE Healthcare
AstraZeneca
Novocure
Table of Contents
1 Brain Tumor Therapeutics Market Overview
1.1 Product Overview and Scope of Brain Tumor Therapeutics
1.2 Classification of Brain Tumor Therapeutics by Type
1.2.1 Global Brain Tumor Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Brain Tumor Therapeutics Revenue Market Share by Type in 2019
1.2.3 Surgery
1.2.4 Radiation Therapy
1.2.5 Targeted Therapy
1.2.6 Chemotherapy
1.2.7 Immunotherapy
1.3 Global Brain Tumor Therapeutics Market by Application
1.3.1 Overview: Global Brain Tumor Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Oncology Treatment Centers
1.3.4 Others
1.4 Global Brain Tumor Therapeutics Market by Regions
1.4.1 Global Brain Tumor Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Brain Tumor Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Brain Tumor Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Brain Tumor Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Brain Tumor Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Brain Tumor Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Brain Tumor Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Philips Healthcare
2.2.1 Philips Healthcare Details
2.2.2 Philips Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Philips Healthcare SWOT Analysis
2.2.4 Philips Healthcare Product and Services
2.2.5 Philips Healthcare Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hitachi Medical
2.5.1 Hitachi Medical Details
2.5.2 Hitachi Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hitachi Medical SWOT Analysis
2.5.4 Hitachi Medical Product and Services
2.5.5 Hitachi Medical Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 DelMar Pharmaceuticals
2.7.1 DelMar Pharmaceuticals Details
2.7.2 DelMar Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 DelMar Pharmaceuticals SWOT Analysis
2.7.4 DelMar Pharmaceuticals Product and Services
2.7.5 DelMar Pharmaceuticals Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GE Healthcare SWOT Analysis
2.8.4 GE Healthcare Product and Services
2.8.5 GE Healthcare Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 AstraZeneca SWOT Analysis
2.9.4 AstraZeneca Product and Services
2.9.5 AstraZeneca Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novocure
2.10.1 Novocure Details
2.10.2 Novocure Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novocure SWOT Analysis
2.10.4 Novocure Product and Services
2.10.5 Novocure Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Brain Tumor Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Brain Tumor Therapeutics Players Market Share
3.2.2 Top 10 Brain Tumor Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Brain Tumor Therapeutics Revenue and Market Share by Regions
4.2 North America Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Brain Tumor Therapeutics Revenue by Countries
5.1 North America Brain Tumor Therapeutics Revenue by Countries (2015-2020)
5.2 USA Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Brain Tumor Therapeutics Revenue by Countries
6.1 Europe Brain Tumor Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Brain Tumor Therapeutics Revenue by Countries
7.1 Asia-Pacific Brain Tumor Therapeutics Revenue by Countries (2015-2020)
7.2 China Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Brain Tumor Therapeutics Revenue by Countries
8.1 South America Brain Tumor Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Brain Tumor Therapeutics by Countries
9.1 Middle East & Africa Brain Tumor Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Brain Tumor Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Brain Tumor Therapeutics Market Forecast by Type (2019-2024)
10.3 Surgery Revenue Growth Rate (2015-2025)
10.4 Radiation Therapy Revenue Growth Rate (2015-2025)
10.5 Targeted Therapy Revenue Growth Rate (2015-2025)
10.6 Chemotherapy Revenue Growth Rate (2015-2025)
10.7 Immunotherapy Revenue Growth Rate (2015-2025)
11 Global Brain Tumor Therapeutics Market Segment by Application
11.1 Global Brain Tumor Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Brain Tumor Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Oncology Treatment Centers Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Brain Tumor Therapeutics Market Size Forecast (2021-2025)
12.1 Global Brain Tumor Therapeutics Market Size Forecast (2021-2025)
12.2 Global Brain Tumor Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Brain Tumor Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Brain Tumor Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Brain Tumor Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Brain Tumor Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Brain Tumor Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Brain Tumor Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Brain Tumor Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Brain Tumor Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Brain Tumor Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Brain Tumor Therapeutics Major Business
Table 7. Pfizer Brain Tumor Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Brain Tumor Therapeutics Product and Solutions
Table 10. Pfizer Brain Tumor Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Philips Healthcare Corporate Information, Location and Competitors
Table 12. Philips Healthcare Brain Tumor Therapeutics Major Business
Table 13. Philips Healthcare Brain Tumor Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Philips Healthcare SWOT Analysis
Table 15. Philips Healthcare Brain Tumor Therapeutics Product and Solutions
Table 16. Philips Healthcare Brain Tumor Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck Brain Tumor Therapeutics Major Business
Table 19. Merck Brain Tumor Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck Brain Tumor Therapeutics Product and Solutions
Table 22. Merck Brain Tumor Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Brain Tumor Therapeutics Major Business
Table 25. Novartis Brain Tumor Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Brain Tumor Therapeutics Product and Solutions
Table 28. Novartis Brain Tumor Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Hitachi Medical Corporate Information, Location and Competitors
Table 30. Hitachi Medical Brain Tumor Therapeutics Major Business
Table 31. Hitachi Medical Brain Tumor Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Hitachi Medical SWOT Analysis
Table 33. Hitachi Medical Brain Tumor Therapeutics Product and Solutions
Table 34. Hitachi Medical Brain Tumor Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Roche Corporate Information, Location and Competitors
Table 36. Roche Brain Tumor Therapeutics Major Business
Table 37. Roche Brain Tumor Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Roche SWOT Analysis
Table 39. Roche Brain Tumor Therapeutics Product and Solutions
Table 40. Roche Brain Tumor Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. DelMar Pharmaceuticals Corporate Information, Location and Competitors
Table 42. DelMar Pharmaceuticals Brain Tumor Therapeutics Major Business
Table 43. DelMar Pharmaceuticals Brain Tumor Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. DelMar Pharmaceuticals SWOT Analysis
Table 45. DelMar Pharmaceuticals Brain Tumor Therapeutics Product and Solutions
Table 46. DelMar Pharmaceuticals Brain Tumor Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. GE Healthcare Corporate Information, Location and Competitors
Table 48. GE Healthcare Brain Tumor Therapeutics Major Business
Table 49. GE Healthcare Brain Tumor Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. GE Healthcare SWOT Analysis
Table 51. GE Healthcare Brain Tumor Therapeutics Product and Solutions
Table 52. GE Healthcare Brain Tumor Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. AstraZeneca Corporate Information, Location and Competitors
Table 54. AstraZeneca Brain Tumor Therapeutics Major Business
Table 55. AstraZeneca Brain Tumor Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. AstraZeneca SWOT Analysis
Table 57. AstraZeneca Brain Tumor Therapeutics Product and Solutions
Table 58. AstraZeneca Brain Tumor Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Novocure Corporate Information, Location and Competitors
Table 60. Novocure Brain Tumor Therapeutics Major Business
Table 61. Novocure Brain Tumor Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Novocure SWOT Analysis
Table 63. Novocure Brain Tumor Therapeutics Product and Solutions
Table 64. Novocure Brain Tumor Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Brain Tumor Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 66. Global Brain Tumor Therapeutics Revenue Share by Players (2015-2020)
Table 67. Global Brain Tumor Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Brain Tumor Therapeutics Revenue Market Share by Regions (2015-2020)
Table 69. North America Brain Tumor Therapeutics Revenue by Countries (2015-2020)
Table 70. North America Brain Tumor Therapeutics Revenue Market Share by Countries (2015-2020)
Table 71. Europe Brain Tumor Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Brain Tumor Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Brain Tumor Therapeutics Revenue by Countries (2015-2020)
Table 74. South America Brain Tumor Therapeutics Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Brain Tumor Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Brain Tumor Therapeutics Revenue Market Share by Countries (2015-2020)
Table 77. Global Brain Tumor Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 78. Global Brain Tumor Therapeutics Revenue Share by Type (2015-2020)
Table 79. Global Brain Tumor Therapeutics Revenue Forecast by Type (2021-2025)
Table 80. Global Brain Tumor Therapeutics Revenue by Application (2015-2020)
Table 81. Global Brain Tumor Therapeutics Revenue Share by Application (2015-2020)
Table 82. Global Brain Tumor Therapeutics Revenue Forecast by Application (2021-2025)
Table 83. Global Brain Tumor Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Brain Tumor Therapeutics Picture
Figure 2. Global Brain Tumor Therapeutics Revenue Market Share by Type in 2019
Figure 3. Surgery Picture
Figure 4. Radiation Therapy Picture
Figure 5. Targeted Therapy Picture
Figure 6. Chemotherapy Picture
Figure 7. Immunotherapy Picture
Figure 8. Brain Tumor Therapeutics Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Oncology Treatment Centers Picture
Figure 11. Others Picture
Figure 12. Global Brain Tumor Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Brain Tumor Therapeutics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Brain Tumor Therapeutics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Brain Tumor Therapeutics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Brain Tumor Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Brain Tumor Therapeutics Revenue Market Share by Regions in 2018
Figure 26. North America Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. South America Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. North America Brain Tumor Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Brain Tumor Therapeutics Revenue Market Share by Countries in 2019
Figure 33. USA Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Brain Tumor Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Brain Tumor Therapeutics Revenue Market Share by Countries in 2019
Figure 38. Germany Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. UK Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. France Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Brain Tumor Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Brain Tumor Therapeutics Revenue Market Share by Countries in 2019
Figure 45. China Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. India Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. South America Brain Tumor Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Brain Tumor Therapeutics Revenue Market Share by Countries in 2019
Figure 52. Brazil Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Brain Tumor Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Brain Tumor Therapeutics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Brain Tumor Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. Global Brain Tumor Therapeutics Revenue Share by Type (2015-2020)
Figure 61. Global Brain Tumor Therapeutics Revenue Share by Type in 2019
Figure 62. Global Brain Tumor Therapeutics Market Share Forecast by Type (2021-2025)
Figure 63. Global Surgery Revenue Growth Rate (2015-2020)
Figure 64. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 65. Global Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 66. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 67. Global Immunotherapy Revenue Growth Rate (2015-2020)
Figure 68. Global Brain Tumor Therapeutics Revenue Share by Application (2015-2020)
Figure 69. Global Brain Tumor Therapeutics Revenue Share by Application in 2019
Figure 70. Global Brain Tumor Therapeutics Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Oncology Treatment Centers Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Brain Tumor Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Brain Tumor Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Brain Tumor Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Europe Brain Tumor Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Brain Tumor Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. South America Brain Tumor Therapeutics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Brain Tumor Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
固形腫瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Solid Tumor Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 156810 million by 2025, from USD 114670 million in 2019. The Solid Tumor…- 腫瘍治療フィールド（TTFields）の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tumor Treating Fields (TTFields) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor Treati…
- 脳動脈瘤治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Brain Aneurysm Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Brain Aneurysm Treat…
- 黒色腫治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Melanoma Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Melanoma Therapeutics m…
- 移行上皮がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Transitional Cell Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Transit…